ETHIONAMIDE | ETHIONAMIDE | ATC J04AD03
ANTIINFECTIVES TUBERCULOSTATIC ANTIFUNGAL ANTIBIOTIC ANTIBACTERIAL ANTITUBERCULAR AGENTS FATTY ACID SYNTHESIS INHIBITORS LEPROSTATIC AGENTS | ORAL | Cmax 13 MICROMOLAR Tmax 1.02 HOUR VD 93.5 LITER PPB 30 PERCENT Cl 33.7 LITER / HOUR (EQN) HT 1.92 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | ETHA-ENCODED NADPH-SPECIFIC FAD-CONTAINING MONO-OXYGENASE (ETHA) (PMID20974869) | ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE INHIBITOR CHEMBL1849 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE P9WGR1 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH] MYCOBACTERIUM TUBERCULOSIS ENZYME REDUCTASE | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |